News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Myeloma Paper of the Day, July 26th, Suggested by Robert Orlowski
Jul 26, 2025, 15:43

Myeloma Paper of the Day, July 26th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Case series of elranatamab for relapsed and/or refractory advanced stage AL amyloidosis finds 100% ORR and 67% CR rate; median time to heme response of 9 days (6-24), translating into cardiac and renal responses at 3-6 months.”

Title: Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory Immunoglobulin Light-Chain Amyloidosis

Authors: Pedro Vianna, Rajshekhar Chakraborty, Shahrier Hossain, Divaya Bhutani, Shannon Miller, Annemarie Rossi, Sarah AM Cuddy, Rodney H Falk, Suzanne Lentzsch, Jacob Laubach, Giada Bianchi

You can read the Full Article in Blood.

Myeloma Paper of the Day, July 26th, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

AL Amyloidosis amyloidosis Annemarie Rossi cancer Divaya Bhutani Giada Bianchi Jacob Laubach Myeloma Myeloma Paper of the Day OncoDaily Oncology Pedro Vianna Rajshekhar Chakraborty Robert Orlowski Rodney H Falk Sarah AM Cuddy Shahrier Hossain Shannon Miller Suzanne Lentzsch
Special Coverage
Opinion
Jul 26, 2025, 20:53
Patrick Hwu: Sarcoma is Rare and Complex
Blog
Jul 26, 2025, 20:13
Ready to Take Your Cancer Research Career to the Next Level? - EACR
Blog
Jul 26, 2025, 20:00
EU’s Medicine Strategy is Focused on Supply Chains, But Overlooks the Deeper Risk
Blog
Jul 26, 2025, 19:45
Siddharth Sreemahadevan: I was Honored to Be Declared Second Runner-Up in the 8th SPEAK Lymphoma Programme
Opinion
Jul 26, 2025, 19:31
The AACR Immuno-Oncology Research Fellowships Provide $130,000 to Support Clinical Fellows
Blog
Jul 26, 2025, 19:14
Bishal Gyawali: Calling the Family of My Patients After They Have Passed Away - It’s the Least We Can Do
Science
Jul 26, 2025, 18:38
Incorporating Evidence-Based Approaches for Patients With GI Cancers - Society for Integrative Oncology
Blog
Jul 26, 2025, 17:31
Massimo Di Maio: A Great Opportunity Of Scientific And Cultural Exchange In Beijing
Blog
Jul 26, 2025, 16:51
The Role of Peer-to-Peer Fundraising - Conquer Cancer, The ASCO Foundation
Insight
Jul 26, 2025, 16:40
World Hepatitis Day - ELPA
Career
Jul 26, 2025, 15:51
Alisher Kahharov Has Started a New Role as Head of the Breast Cancer Surgery Department at the National Cancer Center
Science
Jul 26, 2025, 15:43
Myeloma Paper of the Day, July 26th, Suggested by Robert Orlowski